Biotech company Biogen lowered its full-year profit forecast, citing higher costs related to its purchase of drug maker Reata Pharmaceuticals as well as the launch of its Alzheimer's drug.
Share:
More In Business
Bacon Prices Could Get Sizzling
Bacon Prices Could Get Sizzling
Ken Paxton's Lawyers Request Fraud Trial Delay
Ken Paxton's Lawyers Request Fraud Trial Delay
Bud Light Parent Says US Market Share Stabilizing After Influencer Controversy
Bud Light's parent company expressed confidence Thursday that its U.S. market share has stabilized after a promotion with a transgender influencer cost it sales.
Mortgage Rates Tick Higher
The average long-term U.S. mortgage rate rose again this week, bad news for Americans seeking to upgrade or buy their first home.
Earnings Season Kicks Off as Apple, Amazon Set to Report Later Thursday
Earnings kicked off into high gear as Anheuser-Busch posted results on Thursday as Apple and Amazon are set to announce their financials later in the day.
Adidas Makes $437M From Yeezy Sneakers
Adidas has made $437 million from the first release of Yeezy sneakers since cutting ties with Ye.
Fitch Downgrades Fannie Mae and Freddie Mac
Fitch Downgrades Fannie Mae and Freddie Mac
Stocks Tumble, But U.S. Credit Downgrade Doesn't Shake Markets
Investors weren't jolted by the downgrade because they already know the fractured state of U.S. politics, the size of the country's public debt, and the challenges it faces to pay for Social Security, Medicare and other expenses.
How to Save Money on Lighting
How to Save Money on Lighting
